[Selected safety-relevant medication processes in Swiss nursing homes: Current state of affairs and optimization potentials].

Niederhauser, Andrea; Brühwiler, Lea D; Fishman, Liat; Schwappach, David LB (2019). [Selected safety-relevant medication processes in Swiss nursing homes: Current state of affairs and optimization potentials]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 146, pp. 7-14. Elsevier, Urban & Fischer 10.1016/j.zefq.2019.06.005

[img]
Preview
Text
Niederhauser ZEvidFortbildQualGesundhwes 2019.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (607kB) | Preview

BACKGROUND

Reducing adverse drug events in nursing homes is a central patient safety concern. The aim of this study was to assess how often selected medication processes to increase medication safety are already implemented in Swiss nursing homes and to examine how nursing homes that have not yet implemented these processes can be characterized based on their organizational features.

METHODS

Cross-sectional survey study among directors of nursing in Swiss nursing homes.

RESULTS

420 of 1,525 invited individuals participated in the survey (response rate: 27.5 %). Of these, 65.0 % stated that regular systematic medication reviews have been provided in their institution. 9.5 % of the nursing homes use a list to identify potentially inappropriate medication, and 6.7 % of the nursing homes have a standardized process to monitor side effects of medications. 66.0 % of the participating nursing homes have implemented at least one of these three processes, 34.0 % of the participating nursing homes have not implemented any of the three processes. Statistically significant differences in process implementation were found according to the geographical location of the nursing home, the type of documentation used for medications, the physician model, the number of external general practitioners, as well as the medication supply channel and the legal obligation to cooperate with pharmacists. No differences were found with regard to the nursing home size.

CONCLUSION

In Swiss nursing homes, central safety-relevant medication processes have not yet been implemented nationwide. In particular, implementation is not widespread in nursing homes where medical care for their residents is provided by many different external general practitioners. The organizational features need to be taken into account to successfully implement quality improvement measures.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Schwappach, David

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1865-9217

Publisher:

Elsevier, Urban & Fischer

Language:

German

Submitter:

Doris Kopp Heim

Date Deposited:

15 Aug 2019 16:41

Last Modified:

10 Mar 2020 11:35

Publisher DOI:

10.1016/j.zefq.2019.06.005

PubMed ID:

31375396

Uncontrolled Keywords:

Alters- und Pflegeheime Patientensicherheit Polymedikation Potenziell inadäquate Medikamente Langzeitpflege long-term care nursing homes patient safety polypharmacy potentially inappropriate medication list

BORIS DOI:

10.7892/boris.132630

URI:

https://boris.unibe.ch/id/eprint/132630

Actions (login required)

Edit item Edit item
Provide Feedback